Comment on Cardiovascular Events and Androgen Receptor Signaling Inhibitors in Advanced Prostate Cancer-Reply

被引：0
|
作者：
El-Taji, Omar [1 ,2 ,3 ]
Sachdeva, Ashwin [1 ,2 ]
机构：
[1] Univ Manchester, Div Canc Sci, Genito Urinary Canc Res Grp, Manchester, England
[2] Christie NHS Fdn Trust, Dept Surg, Manchester, England
[3] Northern Care Alliance NHS Fdn Trust, Salford Royal Hosp, Dept Urol, Manchester, England
来源：
JAMA ONCOLOGY | 2024年 / 10卷 / 12期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1001/jamaoncol.2024.4584
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1731 / 1732
页数：2
相关论文
共 50 条
  • [41] Neoadjuvant Exercise Therapy in Patients With Prostate Cancer-Reply
    Jones, Lee W.
    Ehdaie, Behfar
    Boutros, Paul C.
    JAMA ONCOLOGY, 2025, 11 (02)
  • [42] Cell-penetrating bispecific antibodies for targeting androgen receptor signaling in advanced prostate cancer
    Goicochea, Nancy L.
    Garnovskaya, Maria
    Blanton, Mary
    Chan, Grace
    Weisbart, Richard
    Lilly, Michael
    CANCER RESEARCH, 2015, 75
  • [43] Androgen suppression and irradiation for locally advanced prostate cancer - Reply
    Bolla, M
    LANCET, 2002, 360 (9349): : 1987 - 1988
  • [44] Androgen Deprivation Therapy/Androgen Receptor Signaling Inhibitor Treatments for Prostate Cancer: Pathophysiology and Review of Effects on Cardiovascular Disease
    Orji, Richard
    Morgans, Alicia
    Jahangir, Eiman
    Markson, Favor
    Ilelaboye, Ayodeji
    Tan, Alan
    Okwuosa, Tochukwu M.
    SOUTHERN MEDICAL JOURNAL, 2024, 117 (05) : 245 - 253
  • [45] Androgen receptor antagonism and impact on inhibitors of androgen synthesis in prostate cancer therapy
    Njar, Vincent C. O.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S128 - S131
  • [46] Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens EDITORIAL COMMENT Reply
    不详
    JOURNAL OF UROLOGY, 2018, 200 (05): : 980 - 980
  • [47] Cardiovascular Adverse Events Associated With Androgen Receptor-targeted Therapy Used in the Treatment of Prostate Cancer
    Shrestha, Bishesh
    Gouli, Sugam
    Shrestha, Asis
    CIRCULATION, 2020, 142
  • [48] Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities
    Lu-Yao, Grace
    Nikita, Nikita
    Keith, Scott W.
    Nightingale, Ginah
    Gandhi, Krupa
    Hegarty, Sarah E.
    Rebbeck, Timothy R.
    Chapman, Andrew
    Kantoff, Philip W.
    Cullen, Jennifer
    Gomella, Leonard
    Kelly, William Kevin
    EUROPEAN UROLOGY, 2020, 77 (02) : 158 - 166
  • [49] Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
    Philip A. Watson
    Vivek K. Arora
    Charles L. Sawyers
    Nature Reviews Cancer, 2015, 15 : 701 - 711
  • [50] Re: A Somatically Acquired Enhancer of the Androgen Receptor is a Noncoding Driver in Advanced Prostate Cancer Editorial Comment
    Atala, Anthony
    JOURNAL OF UROLOGY, 2019, 201 (02): : 230 - 230
12345